RFP
KYMR icon

Root Financial Partners’s Kymera Therapeutics KYMR Stock Holding History

Root Financial Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80
Closed -$6.66K – 1923
2026
Q1 		$6.66K Sell
80
-4
-5% -$317 ﹤0.01% 1837
2025
Q4 		$6.54K Buy
84
+44
+110% +$2.97K ﹤0.01% 1673
2025
Q3 		$2.26K Buy
+40
New +$1.8K ﹤0.01% 1936

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Root Financial Partners's KYMR Position: Q2 2026 in Review

Root Financial Partners sold out of Kymera Therapeutics (KYMR) in Q2 2026, closing a stake of 80 shares — an estimated $6.66K sold.

Root Financial Partners first reported a position in KYMR in Q3 2025 and held it in 3 quarters. The position peaked at $6.66K in Q1 2026. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Root Financial Partners reported no remaining Kymera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 80 Kymera Therapeutics shares in Q2 2026, an estimated $6.66K.
  • Root Financial Partners first reported a position in Kymera Therapeutics in Q3 2025 and held it in 3 quarters.
  • Root Financial Partners's Kymera Therapeutics position peaked at $6.66K in Q1 2026.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.